8 Followers on Owler
KalVista is a Massachusetts-based pharmaceutical company that researches, develops, and commercializes small molecule protease inhibitors for the treatment of HAE diseases... Read more
OverviewCompetitorsAcquisitionsFundingNews & Insights
KalVista is a Massachusetts-based pharmaceutical company that researches, develops, and commercializes small molecule protease inhibitors for the treatment of HAE diseases... Read more
KalVista Pharmaceuticals CEO: Benjamin L. Palleiko

CEO

Benjamin L. Palleiko

CEO Approval Rating

82/100

2004

PublicAcquired by Chiesi Farmaceutici S.p.A.NASDAQKALV

Pharmaceuticals & Biotechnology
Biotechnology
2836 NAICS listing

Annual Revenue
$40.9M
Employees
100
Funding
$234.2M
Acquisitions
1

News

Funding
Sep 25, 2025
FinanzNachrichten
KalVista Pharmaceuticals received $125M in Post-IPO Debt Funding

KalVista Pharmaceuticals Competitors

1BioCryst
2Intellia Therapeutics
3Ionis Pharmaceuticals
4Takeda Pharmaceutical
5Pharvaris
6BioMarin
7Aerie
8Exonate
9Icon Bioscience, Inc.
104DMT
Unlock 19 + competitors

Trending Companies